D-0903-2023 Class II Terminated

Recalled by L. Perrigo Company — Allegan, MI

FDA drug recall D-0903-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 16,200 cartons.

Recall Details

Product Type
Drugs
Report Date
Jul 19, 2023
Initiation Date
Feb 9, 2023
Termination Date
Sep 11, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,200 cartons

Product Description

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide within the USA

Code Information

Lot #: 2DV1925, Exp. date 06/23

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0903-2023
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0903-2023. Report a data issue: hello@regdatalab.com.